{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:34:08Z","timestamp":1707525248184},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,21]]},"DOI":"10.7759\/cureus.45666","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T09:08:04Z","timestamp":1695287284000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-diabetic Euglycemic Ketoacidosis in an Adult Patient With Spinal Muscular Atrophy Type II"],"prefix":"10.7759","author":[{"given":"George","family":"Khludenev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Le Cam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bujji B","family":"Ainapurapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: a timely review","volume":"68","author":"Kolb SJ","year":"2011","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy: a timely review. Arch Neurol. 2011, 68:979-84. 10.1001\/archneurol.2011.74","journal-title":"Arch Neurol"},{"key":"ref2","article-title":"Euglycemic diabetic ketoacidosis","author":"Plewa MC","year":"2023","unstructured":"Plewa MC, Bryant M, King-Thiele R. Euglycemic diabetic ketoacidosis. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5866.578","article-title":"Euglycaemic diabetic ketoacidosis","volume":"2","author":"Munro JF","year":"1973","unstructured":"Munro JF, Campbell IW, McCuish AC, Duncan LJ. Euglycaemic diabetic ketoacidosis. Br Med J. 1973, 2:578-80. 10.1136\/bmj.2.5866.578","journal-title":"Br Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.1769","article-title":"Euglycaemic ketoacidosis in patients with and without diabetes","volume":"30","author":"Le Neveu F","year":"2013","unstructured":"Le Neveu F, Hywel B, Harvey JN. Euglycaemic ketoacidosis in patients with and without diabetes. Pract Diabetes. 2013, 30:167-71. 10.1002\/pdi.1769","journal-title":"Pract Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-018-0345-y","article-title":"Severe ketoacidosis in a patient with spinal muscular atrophy","volume":"7","author":"Lakkis B","year":"2018","unstructured":"Lakkis B, El Chediak A, Hashash JG, Koubar SH. Severe ketoacidosis in a patient with spinal muscular atrophy. CEN Case Rep. 2018, 7:292-5. 10.1007\/s13730-018-0345-y","journal-title":"CEN Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2862916","article-title":"Euglycemic ketoacidosis in spinal muscular atrophy","volume":"2019","author":"Stoimenis D","year":"2019","unstructured":"Stoimenis D, Spyridonidou C, Theofanidou S, Petridis N, Papaioannou N, Iasonidou C, Kapravelos N. Euglycemic ketoacidosis in spinal muscular atrophy. Case Rep Pediatr. 2019, 2019:2862916. 10.1155\/2019\/2862916","journal-title":"Case Rep Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(94)00100-g","article-title":"Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?","volume":"12","author":"Tein I","year":"1995","unstructured":"Tein I, Sloane AE, Donner EJ, Lehotay DC, Millington DS, Kelley RI. Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?. Pediatr Neurol. 1995, 12:21-30. 10.1016\/0887-8994(94)00100-g","journal-title":"Pediatr Neurol"},{"key":"ref8","article-title":"Biochemistry, gluconeogenesis","author":"Chourpiliadis C","year":"2023","unstructured":"Chourpiliadis C, and Mohiuddin SS. Biochemistry, gluconeogenesis. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-384947-2.00276-2","article-title":"Fatty acids: metabolism","author":"Calder P","year":"2015","unstructured":"Calder P. Fatty acids: metabolism. The encyclopedia of food and health. Caballero B, Finglas P, Toldra F (ed): Academic Press, Oxford, UK; 2015. 632-44. 10.1016\/B978-0-12-384947-2.00276-2"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(95)91439-0","article-title":"Hypoglycaemia in spinal muscular atrophy","volume":"346","author":"Bruce AK","year":"1995","unstructured":"Bruce AK, Jacobsen E, Dossing H, Kondrup J. Hypoglycaemia in spinal muscular atrophy. Lancet. 1995, 346:609-10. 10.1016\/s0140-6736(95)91439-0","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)93426-p","article-title":"Secondary metabolic defects in spinal muscular atrophy type II","volume":"336","author":"Harpey JP","year":"1990","unstructured":"Harpey JP, Charpentier C, Paturneau-Jouas M, Renault F, Romero N, Fardeau M. Secondary metabolic defects in spinal muscular atrophy type II. Lancet. 1990, 336:629-30. 10.1016\/0140-6736(90)93426-p","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1520-7560(199911\/12)15:6<412::aid-dmrr72>3.0.co;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel L","year":"1999","unstructured":"Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999, 15:412-26. 10.1002\/(sici)1520-7560(199911\/12)15:6&lt;412::aid-dmrr72&gt;3.0.co;2-8","journal-title":"Diabetes Metab Res Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012140","article-title":"SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy","volume":"5","author":"Swoboda KJ","year":"2010","unstructured":"Swoboda KJ, Scott CB, Crawford TO, et al.. SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy. PLoS One. 2010, 5:e12140. 10.1371\/journal.pone.0012140","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93100-non-diabetic-euglycemic-ketoacidosis-in-an-adult-patient-with-spinal-muscular-atrophy-type-ii","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:28Z","timestamp":1707509248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93100-non-diabetic-euglycemic-ketoacidosis-in-an-adult-patient-with-spinal-muscular-atrophy-type-ii"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.45666","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,21]]}}}